HOON DAVE S B has a total of 35 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PANGAEA BIOTECH SA, PROGENIKA BIOPHARMA SA and JURILAB LTD OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 27 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hoon Dave S B | 35 |
#2 | Sunami Eiji | 6 |
#3 | Kitago Minoru | 5 |
#4 | Asaga Sota | 4 |
#5 | Umetani Naoyuki | 3 |
#6 | Taback Bret | 3 |
#7 | Amersi Farin | 3 |
#8 | Tanemura Atsushi | 2 |
#9 | Ferrone Soldano | 2 |
#10 | Goto Yasufumi | 2 |
Publication | Filing date | Title |
---|---|---|
US2013178428A1 | Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer | |
EP2619332A2 | Direct blood assay for detection of circulating microrna in cancer patients |